Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel

Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel

BackgroundPatients with prostate cancer treated with stereotactic body radiation therapy (SBRT) may experience gastrointestinal (GI) toxicity. The hydrogel may mitigate this toxicity by reducing the rectal radiation dose. The purpose of this study is to compare rectal radiation dose and GI toxicity...

Full description

Bibliographic Details
Main Authors: Palak Kundu, Eric Y. Lin, Stephanie M. Yoon, Neil R. Parikh, Dan Ruan, Amar U. Kishan, Alan Lee, Michael L. Steinberg, Albert J. Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
hydrogel
prostate cancer
SBRT (stereotactic body radiation therapy)
radiation oncology
outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.853246/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.853246/full

Similar Items